We concluded that a single dose of 2×108 pfu of AdASP-2 vaccine administered 7 days prior to or even on the same day as the infectious challenge can be used as a simple model to elicit protective CD8+ T cells against an otherwise lethal infection with T. cruzi. The gene discussed is CD8A; the disease is infection.